Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?

Nature Clinical Practice Gastroenterology & Hepatology volume 4, pages 422–423 (2007)Cite this article

boxed-textMolenaar IQ et al. (2007) Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 7: 185–194

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kang YG et al. (1987) Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 66: 766–773

    Article  CAS  Google Scholar 

  2. Neuhaus P et al. (1989) Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet 2: 924–925

    Article  CAS  Google Scholar 

  3. De Wolf AM et al. (2001) Hypercoagulability and pulmonary thromboembolism during liver transplantation: what is the role of heparin administration [abstract]. Liver Transplant Surg 7: C–5

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. and M Abecassis is Professor of Surgery and Chief of the Division of Organ Transplantation, A De Wolf is Professor of Anesthesiology, and Chief of Transplant Anesthesiology, at the Northwestern Memorial Hospital, Chicago, IL, USA.,

    Andre De Wolf & Michael Abecassis

Authors
  1. Andre De Wolf
    View author publications

    Search author on:PubMed Google Scholar

  2. Michael Abecassis
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Michael Abecassis.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Wolf, A., Abecassis, M. Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?. Nat Rev Gastroenterol Hepatol 4, 422–423 (2007). https://doi.org/10.1038/ncpgasthep0869

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpgasthep0869

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing